Article Text

Download PDFPDF
Letter
Authors’ reply
  1. S A Harrison1,
  2. B A Neuschwander-Tetri2
  1. 1
    Division of Gastroenterology and Hepatology, Brooke Army Medical Center, San Antonio, Texas, USA
  2. 2
    Department of Internal Medicine, Saint Louis University, St Louis, Missouri, USA
  1. Correspondence to Dr S A Harrison, 3841 Roger Brooke Drive, Fort Sam Houston, TX 78234, USA; Stephen.Harrison{at}amedd.army.mil

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

We appreciate the comments by Fujii and colleagues in reference to our manuscript on the development and validation of the BARD score for identifying patients with non-alcoholic steatohepatitis (NASH) without advanced fibrosis1 and applaud efforts by other investigators to apply the BARD score to their patient populations. The authors conclude that in a study of 122 Japanese patients with non-alcoholic fatty liver …

View Full Text

Footnotes

  • Competing interests None.

  • Provenance and Peer review Not commissioned; not externally peer reviewed.